Sling Therapeutics

About:

Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease.

Twitter/X: SlingTX

Top Investors: The Rise Fund

Description:

Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease, aspiring to improve the lives of patients and their families.

Total Funding Amount:

$35M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)slingtx.com

Founders:

Gary Hammer

Number of Employees:

1-10

Last Funding Date:

2022-06-13

IPO Status:

Private

Industries: